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Abstract 
The most common abnormal parameters that view in seminal fluid analysis in infertile men are low sperm 
concentration, decrease in percentage of sperm progressive and decrease in percentage of normal sperm 
morphology, which constitute more than 80 % of the causes of male infertility, and due to presence of variation 
between several drugs that use to treat the infertility, the current study worked comparison between clomid and 
pregnyl to differentiate what is the best to use it where can be treat more than cause of these reasons. Methods: 
Fifty patients they divided into two groups, each group composed of 25 patients. From all patients in the two 
groups takes two samples of seminal fluid  one before treatment and the other after three months of treatment to 
measure the sperm concentration, percentage of sperm progressive and percentage of normal sperm morphology. 
Results: The first group of the patients treated by clomid they showed significant improvement in sperm 
concentration (P = 0.000), percentage of sperm progressive       (P = 0.012)  and percentage of normal sperm 
morphology (P = 0.036). While the patients in the second group who treated by pregnyl they showed significant 
enhancing in sperm concentration only (P = 0.002). 
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Introduction  
Male infertility define inability of the male to produce women pregnancy during the first year of marriage. There 
are many factors responsible on the infertility which divided to male factors and female factors. Male factors 
form about (30-40)% of infertility{1}. The most important male factors are low spermatozoa count 
(Oligozoospermia), abnormal sperm morphology (teratozoospermia) and poor sperm motility 
(asthenozoospermia){2,3}.  
Low sperm count may be occur due to many causes that lead to defect in spermatogenesis such as hormonal 
deficiency, genetic abnormalities, smoking, exposure to high heat for prolonged periods, impotence and other 
factors{4}. Also use of certain drugs such as cimetidine and spironolactone are interfere with the synthesis of 
sexual hormones and their effects. Cimetidine which is H2 blockers used in the treatment of stomach or duodenal 
ulcer and usually used for long period ( usually six month and more ), this drug is enzyme inhibitor that decrease 
steroid synthesis that is to say it will decrease sexual hormones synthesis which are important in stimulation and 
maintains of spermatogenesis, example of these enzymes are follicle-stimulating hormone, luteinizing hormone 
and testosterone. While spironolactone block androgen receptors and has additional effect which is reducing 17α 
hydroxylase/C17-20 lyase activity, leading to reduced testosterone biosynthesis{5}. 
The belief now  the shape of sperm is considered one of the essential fertile tools. The sperm morphology give 
perception to sperm cell development in the testis during spermatogenesis that is to say the men with abnormal 
sperm mean have defect in cell maturation ( problem in spermatogenesis ) which may lead to failure of the sperm 
to penetrate the eggs and fertilize{6}. The sperm consist of head and neck and midpiece and tail. The head which 
take oval shape has acrosomal region which form about (40-70)% of it and contains the genetic material of the 
father in its nucleus. In the midpiece there are the mitochondria which produce the energy to sperm movement. 
While the tail is important to push the head, toward the egg {7,8}. The abnormalities in the sperm, may be occur 
due to many factors, like chemical exposure, disease, congenital birth defects, and lifestyle habits. In several 
situations, the reasons of abnormalities are unknown. 
Sperm progressive motility, should be considered one of the important factors that affect on the fertilization 
because it is essential for the sperm to pass through the cumulus cell, corona radiate, and finally the zona 
pellucida and then occur fertilization{9}. The most important situations that associated with decrease in sperm 
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progression are increase mitochondrial abnormalities{10} and structural deformities in the flagella{11}. The 
pathological reasons for this problem is related to rise in oxidative factors in the seminal plasma{12}, 
progression in the age {13}, and electromagnetic radiation {14}. 
In the current study we will take two of the most frequent drugs that used in treatment of infertility and show 
their effect on sperm count, sperm progressive, and sperm morphology, which are clomid (Clomiphene citrate) 
and pregnyl (Human chorionic gonadotropin (hCG) ). 
Clomid is the tread name of clomiphene. It is non-steroidal estrogen receptor modulator (estrogen receptor 
antagonist). This drug used in treatment of infertility in both male and female which competitively binds to 
estrogen receptors on the hypothalamus and pituitary gland, so interfering with estrogen’s negative feedback, 
and therefore, may increase luteinizing hormone and follicle-stimulating hormone{15,16}. The result is 
stimulating cells of Leydig  to yield testosterone and cells of Sertoli  to promote testicular environment for 
spermatogenesis{17}. Lower than 5% of patients receive clomiphene may be complain from side effect which 
usually mild and these include weight gain, nausea, change in libido, gynecomastia, visual field changes, allergic 
dermatitis, dizziness and headache {18}.  
Pregnyl market name for human chorionic gonadotropin which is a polypeptide hormone produced by the 
syncytiotrophoblast, part of the placenta, after implantation {19}. Is a heterodimeric composed of  α and a β 
subunit. The α-subunit identical to that of luteinizing hormone, follicle-stimulating hormone, thyroid-stimulating 
hormone. The β subunit is unique for each of these hormones and responsible for their specific functions{20}. 
Higher than 75 percent of the human chorionic gonadotropin are metabolized in the liver; while the remainder is 
excreted by the kidney{19}. Human chorionic gonadotropin can be obtained from two ways, first one by 
extraction from urine of pregnant women. second, by recombinant DNA technology {21}.  
Human chorionic gonadotropin act by stimulation sex steroid secretion by the testis through the activation of the 
LH/hCG receptor which is a type of G-protein-coupled receptor that is present in the Leydig cell membrane. In 
adult male, the activation of this receptor adenylyl cyclase system stimulate the synthesis and secretion of 
testosterone (T) and estradiol (E2). The final effect is stimulation and maintenance of spermatogenesis{22}. The 
side effects of human chorionic gonadotropin include headache, migraines, irritability, edema, depression, 
restlessness, fatigue, gynecomastia, precocious puberty, and renal impairment{23}. 
Materials and Methods  
2.1 Subjects: 
Fifty men of 20-45 years old of admitted to fertility center in AL-Sader medical city were included for this study, 
where they are divided to two groups each group contain twenty five patients ( N=25 ).  Each participant 
provided seminal fluid sample before he take the drug and do  analysis for this samples and measure the sperm 
concentration, percentage of sperm progressive and percentage of normal sperm shape by special technician. 
After which one of the groups (N=25) treated with clomiphene (clomid) and the other group (N=25) treated with 
human chorionic gonadotropin (pregnyl). After three months of treatment  pulled other sample from each person 
of the two groups and then work analysis for these samples and measure the same parameters.  
2.2 Semen analysis:  
After continence period of 3 to 5 days the semen sample of each participant collect in a plastic container which 
should be sterile, wide-mouth and metal-free and via masturbation. After liquefaction usually within 20 to 40 
minutes semen specimens are subject to  analysis. Semen specimens processed by an expert technician 
depending to the fifth edition of WHO laboratory manual for the examination and processing of human 
semen{24}. 
Results 
The study and after the course of treatment which is 3 months appear patients in group one which treated by 
clomid are  benefit more than other patients in second group. 
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As shown in the table-1 and figure-1 patients those taking clomid undergone good improvement in sperm 
concentration (P = 0.000) more than that associated by using pregnyl (P = 0.002).  
 
Table-1: Effect of both Clomid and Pregnyl on sperm concentration. 
(**):Highly significant difference. 
(*):Significant difference. 
 
 
 
 
 
 
 
 
 
Figure-1: Enhancement effect of Clomid and Pregnyl on sperm concentration. 
(**): Highly significant difference. 
(*):Significant difference. 
 
Groups Samples No. 
Sperm concentration 
(million/ml) 
Mean ± S.E.M 
Significant 
Clomid Before 
Clomid After 
25 
25 
9100000 ± 973721.38 
21880000 ± 3439510.62 
0.000** 
Pregnyl Before 
Pregnyl After 
25 
25 
5348000 ± 1079013.75 
10852000 ± 2267172.39 
0.002* 
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While in table-2 and figure-2 appear those treated by clomid obtained on significant enhancement (P = 0.012) in 
percentage of sperm progressive and those treated with pregnyl the enhancement is non-significant (P = 0.330).  
Table-2: Significant effect of Clomid on percentage of sperm progressive versus non- significant effect by 
pregnyl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(*):Significant difference. 
 
 
  
 
 
 
 
 
 
Figure-2: Differentiation between the effect of Clomid and Pregnyl on percentage of sperm progressive.  
(*):Significant difference. 
In table-3 and figure-3 showing the clomid has significant (P = 0.036) effect (increase) on percentage of normal 
sperm morphology while pregnyl lack this effect( P = 0.696).   
Table-3: Comparison between the influence of Clomid and Pregnyl on the percentage of normal sperm 
morphology. 
(*):Significant difference. 
Groups Samples No. 
Sperm Progressive % 
Mean ± S.E.M 
Significant 
Clomid Before 
Clomid After 
25 
25 
19.32 ± 3.79 
27.32 ± 5.27 
0.012* 
Pregnyl Before 
Pregnyl After 
25 
25 
6.40 ± 2.07 
8.76 ± 2.74 
0.330 
Groups Samples No. 
Normal Sperm Morphology % 
Mean ± S.E.M 
Significant 
Clomid Before 
Clomid After 
25 
25 
18.40 ± 3.85 
27.16 ± 4.75 
0.036* 
Pregnyl Before 
Pregnyl After 
25 
25 
18.32 ± 4.78 
20.00 ± 5.29 
0.696 
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Figure-3: Good improvement of the percentage of normal sperm morphology via Clomid and negligible 
increment by Pregnyl. 
(*):Significant difference. 
 
Discussion  
In the time in which we search about drug to treat specific disease clear to us there are many of drugs can be 
used to solve this problem. Previously we use one of this drugs and then check from this regimen to find out the 
range to take advantage. In the last years the selection of treatment to specific disease should be according to 
specific criteria such as who is it of the drugs more suitable, benefit and It can cure this disease by different ways 
that is to say the selected drug can be solves more than one problem which leads to this disease. 
For example in treatment of hyperprolactinemia many of dopamine agonists drugs can be used such as 
cabergoline and bromocriptine in the USA and, additionally, quinagolide in the UK and other countries in 
Europa. But the long acting cabergoline appear to has advantages over than bromocriptine in terms of both 
efficacy and tolerability, and therefore it preferably to use in the treatment of hyperprolactinemia{25}. 
For these reason now many of studies and research make comparison between two or more of drugs that used in 
the same purpose to evaluate these drugs and know what is has advantages more than the other which give 
priority to select it. 
The current study show the clomid has multi-benefits in infertile men more than pregnyl because in addition to 
their high significant effect on sperm concentration (increase) by stimulation of spermatogenesis it also cause 
enhancement in percentage of both sperm progressive and normal sperm morphology, this means the clomid 
improves both the quantity and quality of sperm. 
Clomiphene is a selective modulator of estrogen receptors because it a weak estrogen receptor antagonists so it 
will competes with estradiol on their receptors in hypothalamus, result in blocking the normal feedback 
mechanism of circulating estradiol which leads to prevention the estrogen from limiting of gonadotropin 
releasing hormone production. High level of gonadotropin releasing hormone will stimulate the pituitary gland to 
secrete more luteinizing hormone (LH) and follicle-stimulating hormone (FSH) and then enhance production of 
testosterone by testes which stimulates excess production of sperm via spermatogenesis{26}.  
Researchers opined the elevation in endogenous gonadotropins manifests itself in improving sperm motility, 
sperm concentration and to certain extent sperm morphology{27}. 
In Moradi et al the results showed that clomiphene citrate had significant influence on sperm count, morphology, 
and motility (P=0.01), but non-significant effect on the semen volume (P=0.57){28}.  
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.37, 2015 
 
56 
The study that performed via Rekha et al. reveal that there is significant improvement in sperm concentration, 
percentage of sperm morphology and sperm motility{29}.              
 
References 
1- Thonneau P, Marchand S, Tallec A et al. (1991) Incidence and main causes of infertility in a resident 
population (1,850,000) of three French regions (1988–1989). Hum Reprod 6, 811–816. 
2- World Health Organization (2000) WHO Manual for the Standardised Investigation and Diagnosis of the 
Infertile Couple. Cambridge University Press, Cambridge.  
3- Jungwirth A,Giwercman A, Tournaye H, Diemer T, Kopa Z, DohleG et al. (2012) EAU Working Group on 
Male Infertility. European Association of Urology guidelines on male infertility: the 2012 update. EurUrol 62, 
324–332. 
4- 1. Makar RS, Toth TL (2002) "The evaluation of infertility". Am J Clin Pathol. 117 Suppl: S95–103.  
5- Turner HE, Wass JAH (1997) Gonadal function in men with chronic illness. Clin Endocrinol; 47: 379–403.  
6- Assessing human sperm morphology: top models, underdogs or biometrics? Jacques Auger, Asian Journal of 
Andrology (2010) 12: 36–46. 
7- World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical 
mucus interaction. 4th ed. Cambridge: Cambridge University Press, 1999.  
8- Alaa A. El-Ghobashy And Christopher R. (2003) The Human Sperm Head: A Key for Successful 
Fertilization. West, Journal of Andrology, Vol. 24, No. 2. 
9- Turner, R.M. (2006) Moving to the beat: a review of mammalian sperm motility regulation. Reprod Fertil Dev 
18:25–38. 
10- Kao, S.H., Chao, H.T. and Wei, Y.H. (1998) Multiple deletions of mitochondrial DNA are associated with 
the decline of motility and fertility of human spermatozoa. Mol Hum Reprod 4:657–666.  
11- Chemes, H.E., Olmedo, S.B., Carrere, C., Oses, R., Carizza, C., Leisner, M. and Blaquier, J. (1998) 
Ultrastructural pathology of the sperm flagellum: association between flagellar pathology and fertility prognosis 
in severely asthenozoospermic men. Hum Reprod 13:2521–2526.  
12- Kao, S.H., Chao, H.T., Chen, H.W., Hwang, T.I.S., Liao, T.L. and Wei, Y.H. (2008) Increase of oxidative 
stress in human sperm with lower motility. Fertil Steril 89:1183–1190.  
13- Kidd, S.A., Eskenazi, B. and Wyrobek, A.J. (2001) Effects of male age on semen quality and fertility: a 
review of the literature. Fertil Steril 75:237–248.  
14- Yan, J.G., Agresti, M., Bruce, T., Yan, Y.H., Granlund, A. and Matloub, H.S. (2007) Effects of cellular 
phone emissions on sperm motility in rats. Fertil Steril 88:957–964.  
15- Shelly W, Draper MW, Krishnan V, Wong M, Jaffe RB. (2008) Selective estrogen receptor modulators: an 
update on recent clinical findings. Obstet Gynecol Surv;63:163–81. 
16- Rozati R, Reddy PP, Reddanna P, Mujtaba R. (2002) Role of environmental estrogens in the deterioration of 
male factor fertility. Fertil Steril;Dec78(6):1187-94.  
17- Patankar SS, Kaore SB, Sawane MV, Mishra NV & Deshkar AM. (2007) Effect of clomiphene citrate on 
sperm density in male partners of infertile couples. Indian J Physiol Pharmacol 51, 195–198. 
18- Siddiq FM, Sigman M. (2002) A new look at the medical management of infertility. Urol Clin North Am; 
29: 949-63. 
19- Cole LA (2010) Degradation Products of hCG, Hyperglycosylated hCG, and Free β-Subunit. In: Human 
Chorionic Gonadotropin (hCG) Elsevier Inc pp 109-119. 
20- De Rensis F, Lopez-Gatius F, Garcia-Ispierto I & Techakumpu M (2010) Clinical use of human chorionic 
gonadotropin in dairy cows: An update. Theriogenology 73 1001-1008.  
21- Farrag A, Costantini A, Manna C & Grimaldi G (2008) Recombinant HCG for triggering ovulation increases 
the rate of mature oocytes in women treated for ICSI. J Assist Reprod Genet 25 461-466. 
22- Trinchard-Lugan I, Khan A, Porchet HC & Munfano A (2002) Pharmacokinetics and pharmacodynamics of 
recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reproductive Biomedicine 
Online  4 106–115. 
23- Marion, DW. (2011) Human chorionic gonadotropin: Drug Information. In: Up To Date, Basow, DS (Ed), 
Up To Date, Waltham, MA,. 
24- WHO. (2010) WHO Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus 
Interaction, 5th edn. Cambridge: Cam-bridge University. 
25- Webster J, Piscitelli G, Polli A, Ferrari C, Ismail I, Scanlon 6. MF. (1994) A comparison of cabergoline and 
bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med; 331 : 904-9.  
Advances in Life Science and Technology                                                                                                 www.iiste.org 
ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) 
Vol.37, 2015 
 
57 
26- Ioannidou-Kadis S, Wright PJ, Neely RD, Quinton R (2006) Complete reversal of adult-onset isolated 
hypogonadotropic hypogonadism with clomiphene citrate. Fertil Steril.; 86: 1513.e5-9. 
27- Patankar SS, Kaore SB, Sawane MV, Mishra NV, Deshkar AM. (2007) Effect of clomiphene citrate on 
sperm density in male partners of infertile couples. Indian J Physiol Pharmacol.; 51: 195 –198.[Medline]).  
28- Mahmoudreza M, Asaad M, Mohsen A et al. (2010) Safety and Efficacy of Clomiphene Citrate and L-
Carnitine in Idiopathic Male Infertility. Urol J. 2010;7:188-93.  
29- Rekha S, Vivekanand G, Biswas D et al. (2011) Comparative study of Indigenous drug Addyzoa and 
allopathic drug Clomiphene citrate on seminal quality of male partners of infertile couple. J. B io s c i. Res, .Vol. 
2(4):278-283. 
 
